Global Enteric Disease Testing Market to reach USD 2.6 billion by 2027.Global Enteric Disease Testing Market is valued approximately USD 1.7 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.0 % over the forecast period 2021-2027. Enteric disease infections can be acquired by contaminated food and drink, as well as by coming into contact with the excrement of an infected animal or human. Abdominal pains, vomiting, nausea, and anorexia are frequent symptoms of enteric illnesses, which can cause the body to lose fluids and nutrients. Advances in diagnostic technology have transformed gastrointestinal illness testing, resulting in considerably higher diagnosis rates in symptomatic people. The rise of the enteric disease testing market is mostly due to an increase in the number of cases of food contamination and foodborne illness. Pathogens such as Salmonella are common pollutants in cereals and grains and are typically produced by birds or rats during harvesting. Salmonella may be found in meat, poultry, fruits, and vegetables, among other things. Some cases of diarrhea and cholera have been discovered, with several deaths attributed to Salmonella-infected food. These reasons are helping to fuel the expansion of Salmonella testing in the enteric illness testing industry. In comparison to single plex tests, molecular diagnostic methods such as multiplexed assays are very recent in health care. As a result, multiplexed assay equipment is costly. When compared to single plex assay tests, the cost per multiplexed assay test is lower; nevertheless, the initial expenditure for equipment installation is greater. Furthermore, the expensive cost of this technology stifles market expansion, particularly in underdeveloped countries. As a result, the high cost of the technology is anticipated to be a key stumbling block until local entities provide lower-priced alternatives.


The main regions of Asia Pacific, North America, Europe, Latin America, and the Rest of the World are included in the geographical analysis of the worldwide Enteric Disease Testing market. Growth in the German and UK markets is largely driving the European market. It is also influenced by European food regulations, which have been stressed by National Reference Laboratories (NRLs) and European Reference Laboratories (EURLs) as important in maintaining food standards and protecting consumer health. With a rise in verified human cases in the European Union, campylobacter has become the most often reported food epidemic (EU). The presence of major enteric disease testing companies such as SGS SA (Switzerland), Eurofins Scientific (Luxembourg), and Intertek Group plc (UK) is also fueling the market. These companies are constantly investing and collaborating to develop better and faster testing technologies to aid compliance with various enteric disease regulations.
Major market player included in this report are:
Abbott Laboratories
BD (Becton, Dickinson and company)
Bio-Rad Laboratories Inc.
Biomerica Inc.
Biomerieux SA
Cepheid Inc.
Coris BioConcept
DiaSorin
Meridian Bioscience Inc.
Quest Diagnostic
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Mode of Operation offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Therapeutic:
Campylobacter
Cryptosporidium
E-Coli
Enteroviruses
RhinoViruses
RotaVirus (REOVIRUS)
Salmonellosis
Shigellosis
By Technology:
Molecular Diagnostics
Monoclonal Antibodies
Immunoassays
Differential Light Scattering
Information Technology
Artificial Intelligence
Liposomes
Flow Cytometry
Chromatography
Diagnostic Imaging
Gel Microdroplets
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027

Target Audience of the Global Enteric Disease Testing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors